Free Newsletter
Elan scouts Dublin-area sites for plant
Free newsletter via e-mail
Tools
Elan, Ireland's biggest drugmaker, is hunting the Dublin area for sites for a new $300 million manufacturing plant, with a location near its partner Wyeth in Grangegorman seen as the front runner. The company is also considering sites along Ireland's east coast. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: